Clinical trials
Phase 1 Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 7 |
| Completed | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Yunying Medical Technology | 2 |
| Sichuan University | 2 |
| AstraZeneca | 1 |
| China Medical University, China | 1 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 1 |
| Multitude Therapeutics Inc. | 1 |
| Peking University | 1 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 1 |
| West China Hospital | 1 |
| Yong He | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 12 |
| Colorectal Neoplasms | 4 |
| Lung Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Gastrointestinal Neoplasms | 2 |
| Melanoma | 2 |
| Ovarian Neoplasms | 2 |
| Sarcoma | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.